Send someone a link to this article. They'll recieve an email with a your name, a link to the article and an optional message.

NYSSA The New York State Society of Anesthesiologists, Inc.

Articles written by Melissa A. Kreso

Melissa A. Kreso, M.D., MsBA, FASA, is with the Department of Anesthesiology and Perioperative Medicine at the University of Rochester Medical Center
Melissa A. Kreso, M.D., MsBA, FASA

Volume 77 Number 4

Reducing OR Delays by Optimizing the Regional Anesthesia Team in an Orthopedic Ambulatory Surgery Center: A Quality Improvement Project

Reducing OR Delays by Optimizing the Regional Anesthesia Team in an Orthopedic Ambulatory Surgery Center: A Quality Improvement Project

Our Ambulatory Anesthesiology Division has expanded significantly over the past two years with the creation  of a specialized orthopedic ambulatory surgery center (ASC), leading to a substantial increase in patient volume and regional anesthesia procedures. This growth has enhanced opportunities for anesthesiology resident education, as our ambulatory sites serve the regional rotation for our residency program. However, this growth also underscores the need to optimize our anesthesia services to meet rising clinical demands while upholding high educational standards.

Read the article

Volume 77 Number 2

Phasing Out Desflurane at Three New York State Institutions

Phasing Out Desflurane at Three New York State Institutions

Over the past decade, there has been movement towards eliminating desflurane usage both nationally and internationally, with Scotland, England, and the Canadian province of Newfoundland and Labrador officially phasing out the agent. This article chronicles the journey of three institutions in New York State as they phased out desflurane from their formularies—and provides guidance to other NYS hospitals looking to do the same.

Read the article

Volume 75 Number 2

New ASA Guidelines for Neuromuscular Blockade: Contraceptive Considerations

New ASA Guidelines for Neuromuscular Blockade: Contraceptive Considerations

Since obtaining FDA approval in 2015, the steroidal encapsulating agent sugammadex has become anesthesia providers’ neuromuscular blockade (NMB) reversal agent of choice.

Read the article
NYSSA Supporter
MLMIC Insurance Company
Endorsed Vendors
Charles J. Sellers & Co MLMIC Insurance Company Weiss Zarett Brofman Sonnenklar & Levy, P.C.

Website design, development and hosting by MAjor Designs